Literature DB >> 26595079

Tumorablative haploidentical hematopoietic cell transplantation for treatment of hematologic malignancy in children.

R M Luo1, W M Da1,2, X M Zhang1, Z L Du1, Y J Si1, Y Wang1, Y Yue1, W Chen1, B Hu1, G S Xing1, Z C Feng1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26595079     DOI： 10.1038/bmt.2015.260

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

Authors:  Michel Duval; John P Klein; Wensheng He; Jean-Yves Cahn; Mitchell Cairo; Bruce M Camitta; Rammurti Kamble; Edward Copelan; Marcos de Lima; Vikas Gupta; Armand Keating; Hillard M Lazarus; Mark R Litzow; David I Marks; Richard T Maziarz; David A Rizzieri; Gary Schiller; Kirk R Schultz; Martin S Tallman; Daniel Weisdorf
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

2.  Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

Authors:  Raymond Wong; Munir Shahjahan; Xuemei Wang; Peter F Thall; Marcos De Lima; Issa Khouri; James Gajewski; Jorge Alamo; Daniel Couriel; Borje S Andersson; Michelle Donato; Chitra Hosing; Krishna Komanduri; Paolo Anderlini; Jeffrey Molldrem; Naoto T Ueno; Elihu Estey; Cindy Ippoliti; Richard Champlin; Sergio Giralt
Journal:  Biol Blood Marrow Transplant       Date:  2005-02       Impact factor: 5.742

3.  Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.

Authors:  Dao-Pei Lu; Lujia Dong; Tong Wu; Xiao-Jun Huang; Mei-Jie Zhang; Wei Han; Huan Chen; Dai-Hong Liu; Zhi-Yong Gao; Yu-Hong Chen; Lan-Ping Xu; Yao-Chen Zhang; Han-Yun Ren; Dan Li; Kai-Yan Liu
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

4.  Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group.

Authors:  Thomas Klingebiel; Jacqueline Cornish; Myriam Labopin; Franco Locatelli; Philippe Darbyshire; Rupert Handgretinger; Adriana Balduzzi; Joanna Owoc-Lempach; Franca Fagioli; Reuven Or; Christina Peters; Franco Aversa; Emmanuelle Polge; Giorgio Dini; Vanderson Rocha
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113
  4 in total
  2 in total

1.  Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning.

Authors:  Wu Yamei; Luo Rongmu; Cao Yongbin; Si Yingjian; Li Xiaohong; Zhang Xiaomei; Yan Pei; Du Zhenlan; Wang Haitao; Wang Jing; Wang Bojing; Wu Xiaoxiong; Da Wanming
Journal:  Oncotarget       Date:  2017-07-31

2.  Tumorablative conditioning regimen for haploidentical stem cell transplantation in 102 children with hematologic malignancies: a single-center experience.

Authors:  Luo Rongmu; Zhang Xiaomei; Du Zhenlan; Wang Ya; Chen Wei; Si Yingjian; Gu Wenjing; Xing Guosheng; Wang Yang; Da Wanming
Journal:  Oncotarget       Date:  2017-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.